{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:57:36Z","timestamp":1790009856929,"version":"4.0.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.canlet.2006.02.018","type":"journal-article","created":{"date-parts":[[2006,4,5]],"date-time":"2006-04-05T14:46:34Z","timestamp":1144248394000},"page":"190-200","source":"Crossref","is-referenced-by-count":43,"title":["Specific inhibition of AKT2 by RNA interference results in reduction of ovarian cancer cell proliferation: Increased expression of AKT in advanced ovarian cancer"],"prefix":"10.1016","volume":"246","author":[{"given":"Aurelia","family":"Noske","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Kaszubiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilko","family":"Weichert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Sers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Niesporek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalid","family":"Sehouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Dietel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herman","family":"Lage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Denkert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2006.02.018_bib1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3322\/canjclin.54.1.8","article-title":"Cancer statistics","volume":"54","author":"Jemal","year":"2004","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.canlet.2006.02.018_bib2","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1126\/science.1833819","article-title":"A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region","volume":"254","author":"Bellacosa","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.canlet.2006.02.018_bib3","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1432-1033.1991.tb16305.x","article-title":"Molecular cloning and characterization of a novel putative protein\u2013serine kinase related to the cAMP-dependent and protein kinase C families","volume":"201","author":"Coffer","year":"1991","journal-title":"Eur J. Biochem."},{"key":"10.1016\/j.canlet.2006.02.018_bib4","doi-asserted-by":"crossref","first-page":"9267","DOI":"10.1073\/pnas.89.19.9267","article-title":"AKT2, a putative oncogene encoding a member of a subfamily of protein\u2013serine\/ threonine kinases, is amplified in human ovarian carcinomas","volume":"89","author":"Cheng","year":"1992","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2006.02.018_bib5","first-page":"2973","article-title":"AKT2, a member of the protein kinase B family, is activated by growth factors, v-Ha-ras, and v-src through phosphatidylinositol 3-kinase in human ovarian epithelial cancer cells","volume":"58","author":"Liu","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2006.02.018_bib6","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1101\/gad.13.22.2905","article-title":"Cellular survival: a play in three Akts","volume":"13","author":"Datta","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/j.canlet.2006.02.018_bib7","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0960-9822(06)00122-9","article-title":"Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase B alpha","volume":"7","author":"Alessi","year":"1997","journal-title":"Curr. Biol."},{"key":"10.1016\/j.canlet.2006.02.018_bib8","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1038\/sj.onc.1203598","article-title":"Frequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase\/Akt pathway in human ovarian cancer","volume":"19","author":"Yuan","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2006.02.018_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bbapap.2003.11.009","article-title":"Structure, regulation and function of PKB\/AKT\u2014a major therapeutic target","volume":"1697","author":"Hanada","year":"2004","journal-title":"Biochim. Biophys. Acta C"},{"key":"10.1016\/j.canlet.2006.02.018_bib10","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.282.5392.1318","article-title":"Regulation of cell death protease caspase-9 by phosphorylation","volume":"282","author":"Cardone","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.canlet.2006.02.018_bib11","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0960-9822(99)80265-6","article-title":"Induction of NF-kappaB by the Akt\/PKB kinase","volume":"9","author":"Kane","year":"1999","journal-title":"Curr. Biol."},{"key":"10.1016\/j.canlet.2006.02.018_bib12","doi-asserted-by":"crossref","first-page":"C281","DOI":"10.1152\/ajpcell.00422.2003","article-title":"G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K\/AKT\/ mTOR\/p70S6K1 signaling in human ovarian cancer cells","volume":"287","author":"Gao","year":"2004","journal-title":"Am J. Physiol. Cell Physiol."},{"key":"10.1016\/j.canlet.2006.02.018_bib13","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/ijc.2910640412","article-title":"Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas","volume":"64","author":"Bellacosa","year":"1995","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2006.02.018_bib14","first-page":"2475","article-title":"AKT-1, -2, and -3 are expressed in both normal and tumor tissues of the lung, breast, prostate, and colon","volume":"7","author":"Zinda","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2006.02.018_bib15","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/(SICI)1098-2744(199802)21:2<81::AID-MC1>3.0.CO;2-R","article-title":"Amplification and overexpression of the AKT2 oncogene in a subset of human pancreatic ductal adenocarcinomas","volume":"21","author":"Ruggeri","year":"1998","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.canlet.2006.02.018_bib16","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1073\/pnas.93.8.3636","article-title":"Amplification of AKT2 in human pancreatic cancer cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA","volume":"93","author":"Cheng","year":"1996","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2006.02.018_bib17","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1073\/pnas.84.14.5034","article-title":"Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma","volume":"84","author":"Staal","year":"1987","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2006.02.018_bib18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1136\/jmg.2003.015339","article-title":"Akt activation and localization correlate with tumour invasion and oncogene expression in thyroid cancer","volume":"41","author":"Vasko","year":"2004","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.canlet.2006.02.018_bib19","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1006\/gyno.1998.5051","article-title":"Toward the development of a universal grading system for ovarian epithelial carcinoma","volume":"70","author":"Shimizu","year":"1998","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2006.02.018_bib20","doi-asserted-by":"crossref","first-page":"8653","DOI":"10.1038\/sj.onc.1206920","article-title":"Induction of G0\/G1 cell cycle arrest in ovarian carcinoma cells by the anti-inflammatory drug NS-398, but not by COX-2-specific RNA interference","volume":"22","author":"Denkert","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2006.02.018_bib21","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0002-9440(10)64912-7","article-title":"Expression of Cyclooxygenase 2 is an independent prognostic factor in human ovarian carcinoma","volume":"160","author":"Denkert","year":"2002","journal-title":"Am J. Pathol."},{"key":"10.1016\/j.canlet.2006.02.018_bib22","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1006\/excr.1995.1184","article-title":"Characterization of human ovarian surface epithelial cells immortalized by human papilloma viral oncogenes (HPV-E6E7 ORFs)","volume":"218","author":"Tsao","year":"1995","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.canlet.2006.02.018_bib23","first-page":"1727","article-title":"The PLC-PKC cascade is required for il\u22121beta-dependent Erk and Akt activation: their role in proliferation","volume":"23","author":"Amin","year":"2003","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2006.02.018_bib24","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1074\/jbc.M512167200","article-title":"Protein Kinase C negatively regulates Akt activity and modifies UVC-induced apoptosis in mouse keratinocytes","volume":"281","author":"Li","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2006.02.018_bib25","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0014-5793(03)00523-4","article-title":"Modulation of the classical multidrug resistance (MDR) phenotype by RNA interference (RNAi)","volume":"545","author":"Nieth","year":"2003","journal-title":"Fed. Eur. Biochem. Soc. Lett."},{"key":"10.1016\/j.canlet.2006.02.018_bib26","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ymthe.2004.11.016","article-title":"Reversal of different drug-resistant phenotypes by an autocatalytic multitarget multiribozyme directed against the transcripts of the ABC transporters MDR1\/P-gp, MRP2, and BCRP","volume":"11","author":"Kowalski","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.canlet.2006.02.018_bib27","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1046-2023(02)00023-3","article-title":"Analysis of gene function in somatic mammalian cells using small interfering RNAs","volume":"26","author":"Elbashir","year":"2002","journal-title":"Methods"},{"key":"10.1016\/j.canlet.2006.02.018_bib28","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/35078107","article-title":"Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells","volume":"411","author":"Elbashir","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2006.02.018_bib29","doi-asserted-by":"crossref","first-page":"5241","DOI":"10.1016\/S0021-9258(17)37680-9","article-title":"A specific inhibitor of phosphatidyl-inositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002)","volume":"269","author":"Vlahos","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2006.02.018_bib30","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/nar\/gkg141","article-title":"Functional studies of the PI(3)-kinase signalling pathway employing synthetic and expressed siRNA","volume":"31","author":"Czauderna","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2006.02.018_bib31","first-page":"265","article-title":"Genetics and ovarian carcinoma","volume":"25","author":"Lynch","year":"1998","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.canlet.2006.02.018_bib32","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0002-9440(10)61714-2","article-title":"AKT1\/PKB\u03b1 kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells","volume":"159","author":"Sun","year":"2001","journal-title":"Am J. Pathol."},{"key":"10.1016\/j.canlet.2006.02.018_bib33","doi-asserted-by":"crossref","first-page":"5853","DOI":"10.1038\/sj.onc.1207721","article-title":"AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth","volume":"23","author":"Altomare","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2006.02.018_bib34","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/S0002-9440(10)64681-0","article-title":"Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas","volume":"158","author":"Kurose","year":"2001","journal-title":"Am J. Pathol."},{"key":"10.1016\/j.canlet.2006.02.018_bib35","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1038\/sj.bjc.6601396","article-title":"Incidence, mechanism, and prognostic value of activated AKT in pancreas cancer","volume":"89","author":"Schliemann","year":"2003","journal-title":"Br J. Cancer"},{"key":"10.1016\/j.canlet.2006.02.018_bib36","first-page":"1168","article-title":"Immunohistochemical demonstration of phospho-AKT in high Gleason grade prostate cancer","volume":"4","author":"Malik","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2006.02.018_bib37","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/sj.bjc.6600126","article-title":"Stal O and members of the southeast Sweden breast cancer group. Activation of AKT\/PKB in breast cancer predicts a worse outcome among endocrine treated patients","volume":"86","author":"Perez-Tenorino","year":"2002","journal-title":"Br J. Cancer"},{"key":"10.1016\/j.canlet.2006.02.018_bib38","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/jnci\/djh217","article-title":"Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancer","volume":"96","author":"Cappuzzo","year":"2004","journal-title":"J. Natl Cancer Inst."},{"key":"10.1016\/j.canlet.2006.02.018_bib39","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.canlet.2004.01.017","article-title":"Positive correlation between overexpression of phosphor-BAD with phosphorylated Akt at serine 473 but not threonine 308in colorectal carcinoma","volume":"210","author":"Khor","year":"2004","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2006.02.018_bib40","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1006\/bbrc.1999.0559","article-title":"Identification of a human AKT3 (protein kinase B \u03b3) which contains the regulatory serine phosphorylation site","volume":"257","author":"Nakatani","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2006.02.018_bib41","doi-asserted-by":"crossref","first-page":"21528","DOI":"10.1074\/jbc.274.31.21528","article-title":"Up-regulation of Akt3 in estrogen receptor-deficient breast cancers and androgen-independent prostate cancer lines","volume":"274","author":"Nakatani","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2006.02.018_bib42","doi-asserted-by":"crossref","first-page":"30491","DOI":"10.1074\/jbc.272.48.30491","article-title":"Mitogenic activation, phosphorylation, and nuclear translocation of protein kinase B beta","volume":"272","author":"Meier","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2006.02.018_bib43","doi-asserted-by":"crossref","first-page":"49530","DOI":"10.1074\/jbc.M306782200","article-title":"Isoform-specific regulation of insulin-dependent glucose uptake by Akt\/protein kinase B","volume":"278","author":"Bae","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2006.02.018_bib44","doi-asserted-by":"crossref","first-page":"7569","DOI":"10.1073\/pnas.1332633100","article-title":"Insulin signaling through Akt\/protein kinase B analyzed by small interfering RNA-mediated gene silencing","volume":"100","author":"Jiang","year":"2003","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2006.02.018_bib45","first-page":"196","article-title":"Overexpression of AKT2\/protein kinase B beta leads to up-regulation of beta1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells","volume":"63","author":"Arboleda","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2006.02.018_bib46","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/5042","article-title":"PIK3CA is implicated as a oncogene in ovarian cancer","volume":"21","author":"Shayesteh","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2006.02.018_bib47","first-page":"407","article-title":"Overexpression of Akt\/AKT can modulate chemotherapy-induced apoptosis","volume":"20","author":"Page","year":"2000","journal-title":"Anticancer Res."},{"key":"10.1016\/j.canlet.2006.02.018_bib48","first-page":"7081","article-title":"p53 is a determinant of x-linked inhibitor of apoptosis protein\/Akt-mediated chemoresistence in human ovarian cancer cells","volume":"63","author":"Fraser","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2006.02.018_bib49","first-page":"1862","article-title":"XIAP regulates AKT activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells","volume":"61","author":"Asselin","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2006.02.018_bib50","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ctrv.2003.07.007","article-title":"PI3K\/AKT signaling pathway and cancer","volume":"30","author":"Vara","year":"2004","journal-title":"Cancer Treat. Res."},{"key":"10.1016\/j.canlet.2006.02.018_bib51","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1038\/sj.bjc.6602162","article-title":"Targeting the mammalian target of rapamycin (mTOR): a new approach to treating cancer","volume":"91","author":"Chan","year":"2004","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2006.02.018_bib52","doi-asserted-by":"crossref","first-page":"11397","DOI":"10.1074\/jbc.275.15.11397","article-title":"The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2","volume":"275","author":"Hsu","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2006.02.018_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1158\/1541-7786.632.2.11","article-title":"COX-2 Inhibitor induces apoptosis in breast cancer cells in an in vivo model of spontaneous metastatic breast cancer","volume":"2","author":"Basu","year":"2004","journal-title":"Mol. Cancer Res."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383506001248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383506001248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T23:07:27Z","timestamp":1683414447000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383506001248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":53,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S0304383506001248"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2006.02.018","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}